(Q36305113)

13 August 2017

1 reference

title

Recent developments in veterinary vaccinology (English)

1 reference

13 August 2017

Homayoun Shams

1

1 reference

13 August 2017

1 November 2005

1 reference

13 August 2017

The Veterinary Journal

1 reference

13 August 2017

170

1 reference

13 August 2017

3

1 reference

13 August 2017

289-299

1 reference

Increased ovulation rate in Merino ewes immunized against small synthetic peptide fragments of the inhibin alpha subunit

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Vaccinology: past achievements, present roadblocks and future promises

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Induction of immune responses by DNA vaccines in large animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Vaccines against intracellular pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Current status of flavivirus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

BCG--different strains, different vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Towards development of T-cell vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Vaccine delivery to animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Evaluation of effectiveness of a vaccination program against an infectious disease at the population level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Neonatal immunity and immunisation in early age: lessons from veterinary medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Bacterial antigens elicit T cell responses via adaptive and transitional immune recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Vaccination of chickens with a Salmonella enteritidis aroA live oral Salmonella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Synthetic peptide antigens induce antibodies to Taenia ovis oncospheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Candidate peptide vaccine induced protection against classical swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Immunocastration of colts and immunospeying of fillies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Prime-boost strategies for malaria vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Modern concepts in immune recognition and lymphocyte activation. Relevance for the development of useful vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Weighing the risks and benefits of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Listeria monocytogenes: a live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Assessment of the immunocontraceptive effect of a zona pellucida 3 peptide antigen in wild mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Construction of genetically defined double aro mutants of Salmonella typhi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Enhancement by tumor necrosis factor-alpha of Fc alpha receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Immunogenicity of hepatitis B vaccines: implications of immune memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Active immunization against LHRH: I. Effects of conjugation site and dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Attenuated, Streptomycin-Dependent Salmonella typhi Oral Vaccine: Potential Deleterious Effects of Lyophilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Polysaccharide vaccines as probes of antibody repertoires in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Recent developments in latency and recombination of Aujeszky's disease (pseudorabies) virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Effect of immunization against synthetic peptide sequences of bovine inhibin alpha-subunit on ovulation rate and twin-calving rate in heifers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

7 January 2021

Veterinary vaccinology

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Delivery of epitopes by the Salmonella type III secretion system for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Recent advances in veterinary vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Evaluation of the immunocontraceptive potential of Escherichia coli-expressed recombinant dog ZP2 and ZP3 in a homologous animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

New use of BCG for recombinant vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Nonreplicating vaccinia vector efficiently expresses recombinant genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Diagnostic compatibility of a thymidine kinase, inverted repeat, gI, and gpX modified live gene-deleted PRV vaccine with three differential ELISAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Antigen presentation in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Potency control of modified live viral vaccines for veterinary use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Potency control of modified live viral vaccines for veterinary use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Get into the groove! Targeting antigens to MHC class II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Diva vaccines that reduce virus transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Present and future of veterinary viral vaccinology: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Bacterial vaccines: old and new, veterinary and medical

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Benefits and risks of antibody and vaccine production in transgenic plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

CD8+ T cells in intracellular bacterial infections of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Effects of active immunization against GnRH on serum LH, inhibin A, sexual development and growth rate in Chinese female pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2004.07.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TVJL.2004.07.004

1 reference

13 August 2017

1 reference

PubMed ID

16266843